Catalyst Wire Dossier Catalyst Wire Dossier

PAMELOR

Nortriptyline hydrochloride · SpecGx LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PAMELOR, covering 2007-07-13 to 2019-04-09. Get the full timeline:

Most recent: FDA Approved: PAMELOR — Supplemental Application (SpecGx LLC)

See pricing